[1] 病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8∶324-329.
|
[2]刘崇柏.我国病毒性肝炎人群流行病学特征及流行因素研究[J].中华肝脏杂志, 1998, 6 (2) ∶67-70.
|
[3]巫贵成, 周卫平.乙型肝炎病毒感染的自然史研究进展[J].中华肝脏病杂志, 2001, 9 (1) ∶55-57.
|
[4]赵伟, 刘伟, 罗婵, 等.死胎多脏器组织中HBcAg表达的初步探讨[J].临床肝胆病杂志, 2002, 18 (4) ∶222-223.
|
[5]黄永绥.儿科免疫学[M].湖北∶湖北科学技术出版社, 1998∶10∶8-9.
|
[6]俞蕙, 朱启, 吕晴, 等宫内HBV感染接种乙肝疫苗小儿的细胞免疫功能的研究[J].中华传染病杂志, 1997, 15 (2) ∶76-78.
|
[7]崔雯, 董永绥, 方峰, 等病毒性肝炎T细胞亚群和几种细胞因子变化的研究[J]中华儿科杂志, 1997, 35 (12) ∶641-644
|
[1] | Wanna YANG, Wen XIE. Clinical manifestations and typing of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2021, 37(11): 2525-2529. doi: 10.3969/j.issn.1001-5256.2021.11.004 |
[2] | Zhang Lu, Liu LiNa. Clinical features of autoimmune liver disease complicated by abdominal lymphadenectasis[J]. Journal of Clinical Hepatology, 2017, 33(11): 2173-2178. doi: 10.3969/j.issn.1001-5256.2017.11.025 |
[3] | Ruan JianWen, Gao LiJuan, Su RuKai. Clinical features of patients with acute exacerbation of chronic hepatitis B: an analysis of 74 cases[J]. Journal of Clinical Hepatology, 2016, 32(11): 2096-2098. doi: 10.3969/j.issn.1001-5256.2016.11.017 |
[4] | Gan Yu, Dong Yi, Zhang HongFei, Xu ZhiQiang, Chen DaWei, Wang LiMin, Wang FuChuan, Yan JianGuo, Zhu ShiShu. Clinical characteristics and outcomes of drug-induced liver injury in children: a study of 184 cases[J]. Journal of Clinical Hepatology, 2015, 31(8): 1244-1247. doi: 10.3969/j.issn.1001-5256.2015.08.015 |
[5] | Liu YanMin. The clinical feature and prognosis in patients with drug induced liver injury complicated with positive autoantibodies detection[J]. Journal of Clinical Hepatology, 2012, 28(5): 335-338+342. |
[6] | Feng XianNi. The therapeutic efficacy of Mannatide Tablets in the treatment of Lamivudine-resistant chronic hepatitis B[J]. Journal of Clinical Hepatology, 2010, 26(2): 180-181. |
[8] | Zhang FengXiao, Wu JiZhou, Zheng Yi, Li GuoJian, Chen MaoWei, Wu JianLin, Wei YingHua. Study on the effects of alleles polymorphisms of HLA-A on the state of prognosis of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2008, 24(6): 408-410. |
[10] | Zhang LeiJia, Zhang JinPing, Hu Bing. Relationship between Cytokines in children and HBV DNA in serum, hepatitis B virus markers.[J]. Journal of Clinical Hepatology, 2006, 22(1): 27-28. |
[11] | Zhang ZhaoHua, Qin LaiYing, Liu KuiHua, Wang Lei, Wang YaoZong. The Effects of Early Viral Response (EVR) on The Treatment of Chronic Hepatitis B with Lamivudine[J]. Journal of Clinical Hepatology, 2005, 21(3): 155-156. |
[14] | Shi LiYun, He JianQin, Chen Zhi, Wu LingJiao. The expression and significance of chemokine interferon-inducible protein-10 (IP-10) in chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2003, 19(4): 220-221. |
[15] | Xin YongNing, Sun Ying, Zhang Jian, Lu: WeiHong, Zhang Mei, Chu LeiLei, Li Ning, Sun ZhenJuan. The study of the influence of lamivudine to T-Lymphocyte-subsetes of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2002, 18(3): 192-193. |
[16] | Shi JunPing, Zheng YaQin, Chen HaiYing. Detection of HBV-DNA different exsiting forins in PBMC in patients with chronic hepatitis B and its clinical significance.[J]. Journal of Clinical Hepatology, 2001, 17(4): 227-228. |
[17] | Tan XinCheng, Wang Yun, Zhang XiCheng, Liu ZhiHua, Li XiaoPing, Wang LeNong. The clinical characters of Transfusion transmitted virus positive hepatitis patients[J]. Journal of Clinical Hepatology, 2000, 16(4): 234-235. |